Citations for
1MARK1, MARK2, MARK3, MARK4
Role of individual MARK isoforms in phosphorylation of tau at Ser²⁶² in Alzheimer's disease.
Gu GJ, Lund H, Wu D, Blokzijl A, Classon C, von Euler G, Landegren U, Sunnemark D, Kamali-Moghaddam M.
Neuromolecular Med 15(3):458-69. doi: 10.1007/s12017-013-8232-3. Epub 2013 May 12. 2013
2MARK3, MITF, TFE3
C-TAK1 interacts with microphthalmia-associated transcription factor, Mitf, but not the related family member Tfe3.
Schwarz T, Murphy S, Sohn C, Mansky KC.
Biochem Biophys Res Commun 394(4):890-5. Epub 2010 Mar 7.PMID: 20214879 2010
3MARK3
High expression stability of microtubule affinity regulating kinase 3 (MARK3) makes it a reliable reference gene.
Chia CY, Lim CW, Leong WT, Ling MH.
IUBMB Life 62(3):200-3.PMID: 20087965 2010
4MARK2, MARK3
Loss of Par-1a/MARK3/C-TAK1 kinase leads to reduced adiposity, resistance to hepatic steatosis, and defective gluconeogenesis.
Lennerz JK, Hurov JB, White LS, Lewandowski KT, Prior JL, Planer GJ, Gereau RW 4th, Piwnica-Worms D, Schmidt RE, Piwnica-Worms H.
Mol Cell Biol 30(21):5043-56. Epub 2010 Aug 23. 2010
5MARK1, MARK2, MARK3, MARK4
Structure and regulation of MARK, a kinase involved in abnormal phosphorylation of Tau protein.
Timm T, Marx A, Panneerselvam S, Mandelkow E, Mandelkow EM.
BMC Neurosci 9 Suppl 2:S9. doi: 10.1186/1471-2202-9-S2-S9. Review. 2008
6MARK3
Conformational instability of the MARK3 UBA domain compromises ubiquitin recognition and promotes interaction with the adjacent kinase domain.
Murphy JM, Korzhnev DM, Ceccarelli DF, Briant DJ, Zarrine-Afsar A, Sicheri F, Kay LE, Pawson T.
Proc Natl Acad Sci U S A 104(36):14336-41. Epub 2007 Aug 28.PMID: 17726107 2007
7MARK2, MARK3
New role for hPar-1 kinases EMK and C-TAK1 in regulating localization and activity of class IIa histone deacetylases.
Dequiedt F, Martin M, Von Blume J, Vertommen D, Lecomte E, Mari N, Heinen MF, Bachmann M, Twizere JC, Huang MC, Rider MH, Piwnica-Worms H, Seufferlein T, Kettmann R.
Mol Cell Biol 26(19):7086-102.PMID: 16980613 2006
8MARK1, MARK2, MARK3, MARK4
Regulation of the polarity kinases PAR-1/MARK by 14-3-3 interaction and phosphorylation.
Göransson O, Deak M, Wullschleger S, Morrice NA, Prescott AR, Alessi DR.
J Cell Sci 119(Pt 19):4059-70. Epub 2006 Sep 12.PMID: 16968750 2006
9MARK3
The oncogenic serine/threonine kinase Pim-1 phosphorylates and inhibits the activity of Cdc25C-associated kinase 1 (C-TAK1): a novel role for Pim-1 at the G2/M cell cycle checkpoint.
Bachmann M, Hennemann H, Xing PX, Hoffmann I, Möröy T.
J Biol Chem 279(46):48319-28. Epub 2004 Aug 19.PMID: 15319445 2004
10MARK3, STK11
Regulation of the Wnt signalling component PAR1A by the Peutz-Jeghers syndrome kinase LKB1.
Spicer J, Rayter S, Young N, Elliott R, Ashworth A, Smith D.
Oncogene 22(30):4752-6. 2003
11MARK3
MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption.
Drewes G, et al.
Cell 89 : 297-308. 1997
12MARK3
Assignment of MARK3 alias KP78 to human chromosome band 14q32.3 by in situ hybridization.
Ono T, Kawabe T, Sonta S, Okamoto T.
Cytogenet Cell Genet 79(1-2):101-2. 1997